Anticardiolipin antibodies in polymyalgia rheumatica-Giant cell arteritis: Association with severe vascular complications
- 31 January 1991
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 90 (1) , 474-478
- https://doi.org/10.1016/0002-9343(91)90608-z
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Antiphospholipid antibodies: more than just a disease marker?Immunology Today, 1990
- Chlorpromazine‐induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosisAmerican Journal of Hematology, 1988
- Anticardiolipin antibodies in patients with rheumatic diseasesArthritis & Rheumatism, 1987
- Anticardiolipin antibodies—clinical associationsPostgraduate Medical Journal, 1986
- Anticardiolipin response in acute infectionsClinical Immunology and Immunopathology, 1986
- Elevation of von willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritisArthritis & Rheumatism, 1984
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- In vitro cytotoxicity of human endothelial cells in polymyalgia rheumatica and giant cell arteritisRheumatology International, 1982
- An evaluation of criteria for polymyalgia rheumatica.Annals of the Rheumatic Diseases, 1979
- Temporal ArteritisAnnals of Internal Medicine, 1978